Elevated brain natriuretic peptide is associated with abnormal heart geometry in children with chronic kidney disease

J Hedvig1, L Podracká, D Potoceková

  • 1Department of Pediatrics, Medical Faculty UPJS and DFN, Kosice, Slovak Republic.

Insights

Brain natriuretic peptide (BNP) levels can predict cardiac dysfunction in children with chronic kidney disease (CKD). Elevated BNP in dialysis patients suggests potential cardiac abnormalities in pediatric CKD.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Chronic kidney disease (CKD) in children poses significant risks for cardiovascular complications.
  • Cardiac dysfunction is a common comorbidity in pediatric CKD patients, often undetected.
  • Brain natriuretic peptide (BNP) is a hormone released in response to cardiac stress and volume overload.

Purpose of the Study:

  • To investigate the potential of brain natriuretic peptide (BNP) as a predictor of cardiac dysfunction in pediatric chronic kidney disease (CKD).
  • To explore the relationship between BNP levels, echocardiographic findings, and cardiovascular risk factors in children with CKD.

Main Methods:

  • A cohort of 46 children with CKD (pre-dialysis, dialysis, kidney transplant recipients) and 11 healthy controls were studied.
  • Brain natriuretic peptide (BNP) levels were measured and transformed using logarithmic scales (log(10) BNP).
  • Echocardiography was used to assess cardiac geometry, and associations with risk factors like hypertension and hyperparathyroidism were analyzed.

Main Results:

  • Logarithmically transformed BNP (log BNP) levels were significantly elevated in children undergoing dialysis compared to healthy controls and pre-dialysis patients.
  • Abnormal cardiac geometry, including hypertrophy and remodeling, was identified in over 50% of the pediatric CKD patients.
  • A significant positive correlation was found between log BNP and ventricular hypertrophy, suggesting BNP's role in detecting cardiac changes.

Conclusions:

  • Brain natriuretic peptide (BNP) shows promise as a non-invasive biomarker for predicting abnormal cardiac geometry in children with chronic kidney disease (CKD).
  • Elevated BNP levels in pediatric CKD patients, particularly those on dialysis, warrant further investigation for cardiac dysfunction.
Abstract

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...